VANGUARD GROUP INC 13D/13G Filings for Heron Therapeutics, Inc. (HRTX)

VANGUARD GROUP INC 13D and 13G filings for Heron Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2024-02-13
5:06 pm
Purchase		2023-12-2913GHeron Therapeutics, Inc.
HRTX		VANGUARD GROUP INC8,338,912
5.560%		532,627increase
(+6.82%)		Filing
2023-02-09
11:22 am
Sale		2022-12-3013GHeron Therapeutics, Inc.
HRTX		VANGUARD GROUP INC7,806,285
6.570%		-1,802,760decrease
(-18.76%)		Filing
2022-02-10
08:17 am
Purchase		2021-12-3113GHeron Therapeutics, Inc.
HRTX		VANGUARD GROUP INC9,609,045
9.430%		1,297,277increase
(+15.61%)		Filing
2021-02-10
10:57 am
Purchase		2020-12-3113GHeron Therapeutics, Inc.
HRTX		VANGUARD GROUP INC8,311,768
9.150%		455,202increase
(+5.79%)		Filing